Angimmune LLC - Company Review
Angimmune LLC - Company ReviewSummary
Angimmune LLC (Angimmune) is a biotechnology company that develops immunotoxins for the treatment of cancer and autoimmune diseases. The company’s lead product candidate, Resimmune, an anti-T cell immunotoxin, is being evaluated for the treatment of T cell blood cancers such as Cutaneous T-Cell Lymphoma. Its resimmune finds application in T cell driven autoimmune diseases such as multiple sclerosis, and graft-versus-host disease, subsequent to stem cell or bone marrow transplant, and metastatic melanoma. Angimmune offers immunotoxin molecules, which include truncated diphtheria toxin, fused to a bivalent format of antibody binding fragments. Angimmune is headquartered in Rockville, Maryland, the US.
This comprehensive company report of Angimmune LLC provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.